Nalaganje...
The use of luspatercept for thalassemia in adults
Luspatercept is an activin receptor ligand trap that has been shown to enhance late-stage erythropoiesis in animal models of β-thalassemia. A multicenter, international, phase 2 dose-finding study was initiated in adult patients with β-thalassemia, either non–transfusion-dependent thalassemia (NTDT)...
Shranjeno v:
| izdano v: | Blood Adv |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7805339/ https://ncbi.nlm.nih.gov/pubmed/33570654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002725 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|